Redeye is pleased to note that Smart Eye announced two new interior sensing design wins worth SEK100...
Både försäljning och rörelseresultat överträffade våra förväntningar för fjärde kvartalet.
Alisa Bank reports its H2 results on February 14th.
Q4e: Germany likely stagnant, US solid 12-9x '25e-'26e EV/EBIT, distributor peers at 14-13x De-lever...
Sales +7% and EBIT +34% vs. ABGSCe Organic growth of +13%, above ABGSCe +6% Limited but positive con...
Redeye provides an initial comment on the Q4 2024 report from Catella.
5%/3% adj. EBITA vs ABGSCe/cons in Q4 Estimates likely up low single digit on adj.
Q4 EBIT of SEK 63m, +19% vs. ABGSC and +13% vs. cons.
Redeye comments on Vertiseit’s Q4 report, with ARR and EBITDA-CAPEX roughly matching our expectation...
Redeye views the Q4 report as uneventful in many respects, as most of the events were communicated d...
Redeye retains its view of Hanza following a Q4 report showing a relatively solid performance in a s...
Q4e: organic growth acceleration to 20%, stable margin Small adj.
On February 11th, Eevia Health Plc (publ) (“Eevia”) announced multiple new sales orders for products...
Analyst Group inleder idag den 11:e februari 2024 analysbevakning på Hifab Group (”Hifab”, ”Koncerne...
Redeye offers a preview of Binero's H2-24 results set to be released on February 21.
